154 related articles for article (PubMed ID: 18555905)
1. Early combined immunosuppression in Crohn's disease.
Lees CW; Satsangi J
Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555905
[No Abstract] [Full Text] [Related]
2. Early combined immunosuppression in Crohn's disease.
Badina L; Taddio A; Ventura A
Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555906
[No Abstract] [Full Text] [Related]
3. Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
Teichgräber U; Atreya I; Atreya R; Schwab M; Neurath MF
Inflamm Bowel Dis; 2013; 19(4):E54-5. PubMed ID: 22532373
[No Abstract] [Full Text] [Related]
4. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.
Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ
Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
Seddik M; Melliez H; Seguy D; Viget N; Cortot A; Colombel JF
Inflamm Bowel Dis; 2005 Jun; 11(6):618-20. PubMed ID: 15905713
[No Abstract] [Full Text] [Related]
6. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
7. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Ruffolo C; Scarpa M; Bassi N
N Engl J Med; 2010 Sep; 363(11):1086-7; author reply 1087-8. PubMed ID: 20848681
[No Abstract] [Full Text] [Related]
8. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
9. Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?
Lakatos PL
Rev Recent Clin Trials; 2009 Sep; 4(3):152-8. PubMed ID: 20028325
[TBL] [Abstract][Full Text] [Related]
10. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Bischoff A
MMW Fortschr Med; 2010 Jan; 152(1-2):20. PubMed ID: 20302159
[No Abstract] [Full Text] [Related]
11. Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease.
Kane SV; Jaganathan S; Bedenbaugh AV; Palmer L; Schwartz DA
Curr Med Res Opin; 2014 Sep; 30(9):1821-6. PubMed ID: 24884302
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
Barthel HR; Gille T; Halbsguth A; Kramer M
J Gastroenterol Hepatol; 2005 Sep; 20(9):1464-5. PubMed ID: 16105142
[No Abstract] [Full Text] [Related]
13. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
Seddik M; Meliez H; Seguy D; Viget N; Cortot A; Colombel JF
Inflamm Bowel Dis; 2004 Jul; 10(4):436-7. PubMed ID: 15475754
[TBL] [Abstract][Full Text] [Related]
14. Biological therapy in the management of recent-onset Crohn's disease: why, when and how?
Löwenberg M; Peppelenbosch M; Hommes D
Drugs; 2006; 66(11):1431-9. PubMed ID: 16906776
[TBL] [Abstract][Full Text] [Related]
15. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Herrlinger KR; Stange EF
N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20825325
[No Abstract] [Full Text] [Related]
16. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
[TBL] [Abstract][Full Text] [Related]
17. Mucosal healing in pediatric Crohn's disease: the goal of medical treatment.
D'Haens G
Inflamm Bowel Dis; 2004 Jul; 10(4):479-80. PubMed ID: 15475761
[No Abstract] [Full Text] [Related]
18. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
[No Abstract] [Full Text] [Related]
19. [Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
Rodríguez-Grau Mdel C; Chaparro M; Díaz R; Gisbert JP
Gastroenterol Hepatol; 2014 Jan; 37(1):21-2. PubMed ID: 24029174
[No Abstract] [Full Text] [Related]
20. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
Macdonagh E; Pugh S; Fox R
J Obstet Gynaecol; 2013 Jul; 33(5):530. PubMed ID: 23815219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
